Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

During the Trading Day
0.0579 +0.0016 / +2.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.0544 -0.0034 / -5.88%
Volume: --
Health Technology

Company Description

Endonovo Therapeutics, Inc. is a biotechnology company, which engages in developing off the shelf regenerative products that no longer require the injection of stem cells. The company provides cell free therapeutics harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Its second platform is the development of non invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.

Contact Information

Endonovo Therapeutics, Inc.
6320 Canoga Avenue
Woodland Hills California 91367
P:(800) 701-1223
Investor Relations:



Individual stakeholders18.25%
Mutual fund holders--
Other institutional--

Top Executives

Alan Brian CollierChairman, CEO, CFO & Secretary
Michael Scott MannPresident & Executive VP-Shareholder Relations
Don CalabriaChief Operating Officer
Leonard MakowkaChief Medical Officer
Steven BarnesVice President-Investor Relations